Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plan

The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions of dollars annually.